Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6999-7006

  Gu, Lingjie ^a,b   Weinreb, Ari ^a   Wang, Xu Ping ^a   Zack, Debra J ^c   Qiao, Jian Hua ^a   Weisbart, Richard ^c   Lusis, Aldons J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CHROMOSOME 2; CONTROLLED STUDY; CORONARY BLOOD VESSEL; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC MANIPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHOLESTEROL, DIETARY; CHROMOSOME MAPPING; CORONARY DISEASE; CROSSES, GENETIC; DIET, ATHEROGENIC; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPIDS; LOD SCORE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; QUANTITATIVE TRAIT, HERITABLE; VASCULITIS;

EID: 0032534737     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Boumpas, D. T., H. A. Austin, J. E. Balow, J. H. Klippel, and M. D. Lockshin. 1995. Systemic lupus erythematosus: emerging concepts. Ann. Intern. Med. 122: 940.
2. Kotzin, B. L. 1996. Systemic lupus erythematosus. Cell 85:303.
3. Mackworth-Young, C. 1990. Antiphospholipid: more than just a disease marker? Immunol. Today 11:60.
4. Deapen, D., A. Escalante, L. Weinrib, D. Horwitz, B. Bachman, P. Ror Burman, A. Walker, and T. M. Mack. 1992. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 35:311.
5. Vyse, T. J., and J. A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85:311.
6. Vyse, T. J., and B. L. Kotzin. 1996. Genetic basis of systemic lupus erythematosus. Curr. Opin. Immunol. 8:843.
7. Kono, D. H., and A. N. Theofilopoulos. 1996. Genetic contributions to SLE. J. Autoimmun. 9:437.
8. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
9. Izui, S., V. E. Kelly, K. Masuda, H. Yoshida, J. B. Roths, and E. D. Murphy. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227.
10. Watson, M. L., J. K. Rao, G. S. Gilkeson, P. Ruiz, E. M. Eicher, D. S. Pisetsky, A. Matsuzawa, J. M. Rochelle, and M. F. Seldin. 1992. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176:1645.
11. Weisbart, R. H., D. T. Noritake, A. L. Wong, G. Chan, A. Kacena, and K. K. Colburn. 1990. A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus. J. Immunol. 144: 2653.
12. Qiao, J. H., L. W. Castellani, M. C. Fishbein, and A. J. Lusis. 1993. Immune-complex-mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice. Arterioscler. Thromb. 13:932.
13. Love, J. M., A. M. Knight, M. A. McAleer, and J. A. Todd. 1990. Towards construction of a high-resolution map of the mouse genome using PCR-analyzed microsatellites. Nucleic Acids Res. 18:4123.
14. Dietrich, W. F., H. Katz, S. E. Lincoln, H. S. Shin, S. J. Friedman, N. C. Dracopoli, and E. S. Lander. 1992. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131:423.
15. Lander, E. S., P. Green, J. Abrahamson, A. Barlow, M. J. Daly, S. E. Lincoln, and L. Newberg. 1987. MAPMAKER: an interaction computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1:174.
16. Manly, K. F. 1993. A Macintosh program for storage and analysis of experimental genetic mapping data. Mammal. Genome 4:303.
17. Paterson, A. H., S. Damon, J. D. Hewitt, D. Zamir, H. D. Rabinowitch, S. E. Lincoln, E. S. Lander, and S. D. Tanksley. 1991. Mendelian factors underlying quantitative traits in tomato: comparison across species, generations, and environments. Genetics 127:181.
18. Lander, E. S., and L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:241.
19. Churchill, G. A., and R. W. Doerge. 1994. Empirical threshold values for quantitative trait mapping. Genetics 138:963.
20. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Therfilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91:10168.
21. cg in the heterozygous state on different genetic background. Cell. Immunol. 148:91.
22. Dimitriu-Bona, A., M. Matic, W. Ding, C. P. Yang, and H. Fillit. 1995. Cytotoxicity to endothelial cells by sera from aged MRL/lpr/lpr mice is associated with autoimmunity to cell surface heparan sulfate. Clin. Immunol. Immunopathol. 76:234.
23. Izui, S., M. Iwamoto, L. Fossati, R. Merino, S. Takahashi, and N. Ibnou-Zekri, 1995. The Yaa gene model of systemic lupus erythematosus. Immunol. Rev. 144:137.
24. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219.
25. Drake, C. G., S. K. Babcock, E. Palmer, and B. L. Kotzin. 1994. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW)F1 mice. Proc. Natl. Acad. Sci. USA 91:4062.
26. Drake, C. G., S. J. Rozzo, T. J. Vyse, E. Palmer, and B. L. Kotzin. 1995. Genetic contributions to lupus-like disease in (NZB × NZW)F1 mice. Immunol. Rev. 144:51.
27. Drake, C. G., S. J. Rozzo, H. F. Hirschfeld, N. P. Smamworawong, E. Palmer, and B. L. Kotzin. 1995. Analysis of the New Zealand Black contribution to lupus-like renal disease: multiple genes that operate in a threshold manner. J. Immunol. 154:2441.
28. Vyse, T. J., L. Morel, F. J. Tanner, E. K. Wakeland, and B. L. Kotzin. 1996. Backcross analysis of genes linked to autoantibody production in New Zealand White mice. J. Immunol. 157:2719.
29. Vyse, T. J., C. G. Drake, S. J. Rozzo, E. Roper, S. Izui, and B. L. Kotzin. 1996. Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. J. Clin. Invest. 98:1762.
30. Rozzo, S. J., T. J. Vyse, C. G. Drake, and B. L. Kotzin. 1996. Effects of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis. Proc. Natl. Acad. Sci. USA 93:15164.
31. Mouse Genome Informatics (MGI) Resource, Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor, ME, World Wide Web (URL: http:/www. informatics.jax.org/), Mar 28, 1998.
32. Serreze, D. V., M. Prochazka, P. C. Reifsnyder, M. M. Bridgett, and E. H. Leiter. 1994. Use of recombinant inbred congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J. Exp. Med. 180: 1553.
33. Vidal, S., D. H. Kono, and A. N. Theofilopoulos. 1998. Loci predisposing to autoimmunity in MRL-Faslpr and C57BL/6-Faslpr mice. J. Clin. Invest. 101: 696.
34. Wang, Y., M. Nose, T. Kamoto, M. Nishimura, and H. Hiai. 1997. Host modifier genes affect mouse autoimmunity induced by the lpr gene. Am. J. Pathol. 151: 1791.
35. Lander, E. S., and N. J. Schork. 1994. Genetic dissection of complex traits. Science 265:2037.
36. Prud'homme, G. J., D. H. Kono, and A. N. Theofilopoulos. 1995. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1β, interleukin-1 and interferon-γ mRNA in the lymph nodes of lupus-prone mice. Mol. Immunol. 32:495.
37. Singh, A. K., and T. V. Lebedeva. 1994. Interleukin-1 contributes to high level IgG production in the murine MRL/lpr lupus model. Mol. Immunol. 23:281.
38. Green, M. C. 1989 Catalog of mutant genes and polymorphic loci. In Genetic Variants and Strains of the Laboratory Mouse, 2nd Ed. M. F. Lyon and A. G. Searle, eds. Oxford University Press, Stuttgart, p. 188.
39. Danoff, T. M., P. A. Lalley, Y. S. Chang, P. S. Heege, and E. G. Neilson. 1994. Cloning, genomic organization, and chromosomal localization of the Scya5 gene encoding the murine chemokine RANTES. J. Immunol. 152:1182.
40. Goldstein, R., and F. C. Arnett. 1987. The genetics of rheumatic disease in man. Rheum. Dis. Clin. North Am. 13:487.
41. Reveille, J. D., K. L. Anderson, R. E. Schroehenloher, R. T. Acton, and B. O. Barger. 1991. Restriction fragment length polymorphism analysis of HLA-DR, DQ, DP, and C4 alleles in Caucasians with systemic lupus erythematosus. J. Rheumatol. 18:14.
42. bm12 mice. J. Immunol. 145:94.
43. Harris, E. N., and S. Pierangeli. 1994. Anticardiolipin antibodies: specificity and function. Lupus 3:217.
44. Vaarala, O. 1996. Antiphospholipid antibodies and atherosclerosis. Lupus 5:442.
45. McIntyre, J. A., D. R. Wagenknecht, T. Sugi. 1997. Phospholipid binding plasma proteins required for antiphospholipid antibody detection - an overview. Am. J. Reprod. Immunol. 37:101.
46. Mizutani, H., Y. Kurata, S. Kosugi, M. Shiraga, H. Kashiwagi, Y. Tomiyama, Y. Kanakura, R. A. Good, and Y. Matsuzawa. 1995. Monoclonal anticardiolipin autoantibodies established from the (New Zealand White × BXSB)F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein. Arthritis Rheum. 38:1382.
47. Vaarala, O., M. Puurunen, M. Lukka, G. Alfthan, M. Leirisalo-Repo, K. Aho, and T. Palosuo. 1996. Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein. Clin. Exp. Immunol. 104:269.
48. Johnson, P. A., H. D. Alexander, S. A. McMillan, and A. P. Maxwell. 1997. Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis. Clin. Exp. Immunol. 108:234.
49. Wen, S. F. 1994. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis: potentially reversible disease. Formos. Med. Assoc. 93:545.
50. Gross, W. L. 1995. Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum. Dis. Clin. North Am. 21:987.
51. Tikly, M., S. Burgin, P. Mohanlal, and A. J. Bellingan. 1996. Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Georgia Clin. Rheumatol. 15:261.
52. Mizutani, H., R. W. Engelman, K. Kinjoh, and R. A. Good. 1995. Gastrointestinal vasculitis in autoimmune-prone (NZW × BXSB)F1 mice: association with anticardiolipin autoantibodies. Proc. Soc. Exp. Biol. Med. 209:279.
53. Yui, M. A., K. Muralidharan, B. Moreno-Altamirano, G. Perrin, K. Chestnut, and E. K. Wakeland. 1996. Production of congenic mouse strains carrying NOD-derived diabetogenic genetic intervals: an approach for the genetic dissection of complex traits. Mammal. Genome 7:331.
54. Morel, L., Y. Yu, K. R. Blenman, R. A. Caldwell, and E. K. Wakeland. 1996. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mammal. Genome 1996:335.